- Home
- EFR vs KMDA Comparison
EFR vs KMDA Comparison
Compare EFR & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- KMDA
- Stock Information
- Founded
- EFR 2003
- KMDA 1990
- Country
- EFR United States
- KMDA Israel
- Employees
- EFR N/A
- KMDA N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- KMDA Health Care
- Exchange
- EFR Nasdaq
- KMDA Nasdaq
- Market Cap
- EFR 348.5M
- KMDA 399.7M
- IPO Year
- EFR N/A
- KMDA N/A
- Fundamental
- Price
- EFR $12.13
- KMDA $7.77
- Analyst Decision
- EFR
- KMDA Strong Buy
- Analyst Count
- EFR 0
- KMDA 2
- Target Price
- EFR N/A
- KMDA $13.00
- AVG Volume (30 Days)
- EFR 88.6K
- KMDA 77.9K
- Earning Date
- EFR 01-01-0001
- KMDA 08-13-2025
- Dividend Yield
- EFR 9.43%
- KMDA 2.57%
- EPS Growth
- EFR N/A
- KMDA 31.21
- EPS
- EFR 1.69
- KMDA 0.28
- Revenue
- EFR N/A
- KMDA $167,235,000.00
- Revenue This Year
- EFR N/A
- KMDA $14.51
- Revenue Next Year
- EFR N/A
- KMDA $9.31
- P/E Ratio
- EFR $7.74
- KMDA $28.07
- Revenue Growth
- EFR N/A
- KMDA 11.83
- 52 Week Low
- EFR $10.95
- KMDA $5.08
- 52 Week High
- EFR $13.29
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- EFR 66.26
- KMDA 69.39
- Support Level
- EFR $12.07
- KMDA $7.62
- Resistance Level
- EFR $12.20
- KMDA $7.92
- Average True Range (ATR)
- EFR 0.08
- KMDA 0.21
- MACD
- EFR 0.02
- KMDA 0.01
- Stochastic Oscillator
- EFR 95.56
- KMDA 83.18
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.